ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules, overview, loss of enzyme results in disruption of generation of naturally processed peptides in the endoplasmic reticulum, decreased stability of peptide-MHC class I complexes, and diminished CD8+ T cell responses
ERAP1 does not degrade other substrates of the X-7-amido-4-methylcoumarin form except L-Leu-7-amido-4-methylcoumarin and L-Met-7-amido-4-methylcoumarin
ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules, overview, loss of enzyme results in disruption of generation of naturally processed peptides in the endoplasmic reticulum, decreased stability of peptide-MHC class I complexes, and diminished CD8+ T cell responses
in the presence of aminopeptidase inhibitor amastatin, nitric oxide synthesis in activated RAW264.7 cells is significantly decreased. Subsequently, significant reduction of nitric oxide synthesis is observed in aminopeptidase ERAP1 knockdown cells compared with wild-type cells. This reduction is rescued by exogenously added ERAP1. When peritoneal macrophages prepared from ERAP1 knockout mouse are employed, reduction of nitric oxide synthesis in knockout mouse macrophages is also attributable to ERAP1. In the presence of amastatin, further reduction is observed in knockout mouse-derived macrophages
mice lacking isoform ERAP1 exhibit exaggerated innate immune responses early during pathogen recognition, as characterized by increased activation of splenic and hepatic natural killer and natural killer T-cells and enhanced production of proinflammatory cytokines such as IL12 and MCP1. ERAP1 is playing a critical role in natural killer cell development and function. ERAP1-KO mice show higher frequencies of terminally matured natural killer cells, as well as higher frequencies of licensed natural killer cells expressing the Ly49C and Ly49I receptors which positively correlates with an enhanced natural killer cell activation and IFNc production by ERAP1-KO mice challenged with pro-inflammatory stimuli. During pathogen recognition, ERAP1 regulates IL12 production by CD11c+ dendritic cells specifically
intracellular ERAP1 induces angiogenesis through endothelial integrin activation, while the secreted form of the enzyme suppresses angiogenesis through angiotensin II inactivation. ERAP1 participates in the innate immune response by increasing the production of cytokine receptors. ERAP1 is associated with the MHC class I antigen processing and presentation pathway
generation of ERAP1-knockout mice, which show a shift in the hierarchy of immunodominance in viral infections, even when the responding T-cells have the same T-cell receptor repertoire, mutant immunodominance hierarchy: GP276, NP396, GP33, GP34, GP118, NP205, CD8+ T-cell responses to viral epitopes are altered in transgenic mice, overview